What is a HER2-positive in breast cancer in 2018?

被引：0
|
作者：
Schnitt, S. [1 ]
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-ES1-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES1-1
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [22] Brain metastases in HER2-positive breast cancer
    Lin, Nancy U.
    LANCET ONCOLOGY, 2013, 14 (03): : 185 - 186
  • [23] Cardiotoxicity in HER2-positive breast cancer patients
    Gonciar, Diana
    Mocan, Lucian
    Zlibut, Alexandru
    Mocan, Teodora
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (04) : 919 - 935
  • [24] Is there a role for immunotherapy in HER2-positive breast cancer?
    Holgado, Esther
    Perez-Garcia, Jose
    Gion, Maria
    Cortes, Javier
    NPJ BREAST CANCER, 2018, 4
  • [25] Adjuvant treatment for HER2-positive breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2015, 16 (02): : E59 - E59
  • [26] Treatment Combinations for HER2-Positive Breast Cancer
    Pegram, Mark
    ONCOLOGY-NEW YORK, 2013, 27 (04): : 258 - +
  • [27] Duration of trastuzumab for HER2-positive breast cancer
    Montemurro, Filippo
    Aglietta, Massimo
    LANCET ONCOLOGY, 2013, 14 (08): : 678 - 679
  • [28] Is there a role for immunotherapy in HER2-positive breast cancer?
    Esther Holgado
    Jose Perez-Garcia
    Maria Gion
    Javier Cortes
    npj Breast Cancer, 4
  • [29] Management of HER2-Positive Early Breast Cancer
    Steger, Guenther
    Lueftner, Diana
    Stoeger, Herbert
    Thurlimann, Beat
    Untch, Michael
    BREAST CARE, 2018, 13 (06) : 453 - 455
  • [30] Treatment strategy for HER2-positive breast cancer
    Mukai, Hirofumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 335 - 340
12345